Current Trends in Pharmaceutical Antitrust Litigation: Patent Litigation Settlements, Product Hopping, and REMs
Pharmaceutical competition issues continue to dominate headlines and remain an area of significant focus for federal and state antitrust enforcers and the courts. Join Pepper attorneys Robin P. Sumner and Lindsay D. Breedlove as they discuss how various theories have fared in challenges under the antitrust laws to three types of conduct: “reverse payment” patent litigation settlements, “product hopping,” and abuse of Risk Evaluation and Mitigation Strategies (REMS) systems.
This seminar is approved for one substantive CLE credit in Pennsylvania. Attorneys licensed in New Jersey may claim credit for this program under New Jersey's reciprocity policy.
Philadelphia Country Club
1601 Spring Mill Road
Gladwyne, PA 19035
There is no cost to attend.
Contact Kim MacAlister at email@example.com or 215.981.4249 with any questions.